BE838273A - IMMUNOLOGICAL CYTOTOXIC AGENTS - Google Patents
IMMUNOLOGICAL CYTOTOXIC AGENTSInfo
- Publication number
- BE838273A BE838273A BE164096A BE164096A BE838273A BE 838273 A BE838273 A BE 838273A BE 164096 A BE164096 A BE 164096A BE 164096 A BE164096 A BE 164096A BE 838273 A BE838273 A BE 838273A
- Authority
- BE
- Belgium
- Prior art keywords
- emi
- immunological
- cytotoxic agents
- cytotoxic
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Medicinal Preparation (AREA)
Description
<EMI ID=1.1>
<EMI ID=2.1>
<EMI ID=3.1>
<EMI ID=4.1> <EMI ID=5.1>
<EMI ID=6.1>
<EMI ID=7.1>
<EMI ID=8.1>
<EMI ID=9.1>
<EMI ID=10.1>
<EMI ID=11.1>
<EMI ID=12.1> <EMI ID=13.1>
<EMI ID=14.1>
-ou
<EMI ID=15.1>
<EMI ID=16.1>
<EMI ID=17.1>
<EMI ID=18.1>
<EMI ID=19.1>
<EMI ID=20.1>
<EMI ID=21.1>
<EMI ID=22.1>
cptb
<EMI ID=23.1>
<EMI ID=24.1>
<EMI ID=25.1>
<EMI ID=26.1>
'
<EMI ID=27.1>
<EMI ID=28.1>
CPCQ)
<EMI ID=29.1>
<EMI ID=30.1>
<EMI ID=31.1>
<EMI ID=32.1>
<EMI ID=33.1> <EMI ID=34.1> <EMI ID=35.1>
<EMI ID=36.1>
<EMI ID=37.1>
<EMI ID=38.1>
<EMI ID=39.1>
<EMI ID=40.1>
<EMI ID=41.1>
<EMI ID=42.1> <EMI ID=43.1>
<EMI ID=44.1>
<EMI ID=45.1> <EMI ID=46.1>
<EMI ID=47.1>
<EMI ID=48.1>
<EMI ID=49.1>
<EMI ID=50.1>
<EMI ID=51.1>
<EMI ID=52.1>
<EMI ID=53.1>
<EMI ID=54.1>
<EMI ID=55.1>
<EMI ID=56.1>
<EMI ID=57.1>
<EMI ID=58.1>
<EMI ID=59.1>
<EMI ID=60.1>
<EMI ID=61.1>
Dt
<EMI ID=62.1>
<EMI ID=63.1>
<EMI ID=64.1>
ÉLT
<EMI ID=65.1>
<EMI ID=66.1>
et
<EMI ID=67.1> <EMI ID=68.1> <EMI ID=69.1>
<EMI ID=70.1>
<EMI ID=71.1>
<EMI ID=72.1>
<EMI ID=73.1>
<EMI ID=74.1>
<EMI ID=75.1>
<EMI ID=76.1>
<EMI ID=77.1>
-qui suit"
<EMI ID=78.1>
<EMI ID=79.1>
<EMI ID=80.1>
<EMI ID=81.1> <EMI ID=82.1>
<EMI ID=83.1>
<EMI ID=84.1>
.
<EMI ID=85.1>
<EMI ID=86.1> <EMI ID=87.1>
<EMI ID=88.1>
<EMI ID=89.1>
<EMI ID=90.1>
<EMI ID=91.1>
<EMI ID=92.1>
<EMI ID=93.1> <EMI ID=94.1> <EMI ID=95.1>
<EMI ID=96.1>
<EMI ID=97.1>
<EMI ID=98.1>
<EMI ID=99.1>
<EMI ID=100.1>
<EMI ID=101.1>
<EMI ID=102.1> <EMI ID=103.1>
<EMI ID=104.1>
<EMI ID=105.1> <EMI ID=106.1>
E�KFf� 1�
<EMI ID=107.1>
suit )
<EMI ID=108.1>
<EMI ID=109.1>
<EMI ID=110.1>
<EMI ID=111.1>
<EMI ID=112.1>
<EMI ID=113.1>
VB�te ;
<EMI ID=114.1>
<EMI ID=115.1>
<EMI ID=116.1>
<EMI ID=117.1> <EMI ID=118.1>
<EMI ID=119.1>
<EMI ID=120.1>
<EMI ID=121.1>
<EMI ID=122.1>
<EMI ID = 1.1>
<EMI ID = 2.1>
<EMI ID = 3.1>
<EMI ID = 4.1> <EMI ID = 5.1>
<EMI ID = 6.1>
<EMI ID = 7.1>
<EMI ID = 8.1>
<EMI ID = 9.1>
<EMI ID = 10.1>
<EMI ID = 11.1>
<EMI ID = 12.1> <EMI ID = 13.1>
<EMI ID = 14.1>
-or
<EMI ID = 15.1>
<EMI ID = 16.1>
<EMI ID = 17.1>
<EMI ID = 18.1>
<EMI ID = 19.1>
<EMI ID = 20.1>
<EMI ID = 21.1>
<EMI ID = 22.1>
cptb
<EMI ID = 23.1>
<EMI ID = 24.1>
<EMI ID = 25.1>
<EMI ID = 26.1>
'
<EMI ID = 27.1>
<EMI ID = 28.1>
CPCQ)
<EMI ID = 29.1>
<EMI ID = 30.1>
<EMI ID = 31.1>
<EMI ID = 32.1>
<EMI ID = 33.1> <EMI ID = 34.1> <EMI ID = 35.1>
<EMI ID = 36.1>
<EMI ID = 37.1>
<EMI ID = 38.1>
<EMI ID = 39.1>
<EMI ID = 40.1>
<EMI ID = 41.1>
<EMI ID = 42.1> <EMI ID = 43.1>
<EMI ID = 44.1>
<EMI ID = 45.1> <EMI ID = 46.1>
<EMI ID = 47.1>
<EMI ID = 48.1>
<EMI ID = 49.1>
<EMI ID = 50.1>
<EMI ID = 51.1>
<EMI ID = 52.1>
<EMI ID = 53.1>
<EMI ID = 54.1>
<EMI ID = 55.1>
<EMI ID = 56.1>
<EMI ID = 57.1>
<EMI ID = 58.1>
<EMI ID = 59.1>
<EMI ID = 60.1>
<EMI ID = 61.1>
Dt
<EMI ID = 62.1>
<EMI ID = 63.1>
<EMI ID = 64.1>
ELT
<EMI ID = 65.1>
<EMI ID = 66.1>
and
<EMI ID = 67.1> <EMI ID = 68.1> <EMI ID = 69.1>
<EMI ID = 70.1>
<EMI ID = 71.1>
<EMI ID = 72.1>
<EMI ID = 73.1>
<EMI ID = 74.1>
<EMI ID = 75.1>
<EMI ID = 76.1>
<EMI ID = 77.1>
-following"
<EMI ID = 78.1>
<EMI ID = 79.1>
<EMI ID = 80.1>
<EMI ID = 81.1> <EMI ID = 82.1>
<EMI ID = 83.1>
<EMI ID = 84.1>
.
<EMI ID = 85.1>
<EMI ID = 86.1> <EMI ID = 87.1>
<EMI ID = 88.1>
<EMI ID = 89.1>
<EMI ID = 90.1>
<EMI ID = 91.1>
<EMI ID = 92.1>
<EMI ID = 93.1> <EMI ID = 94.1> <EMI ID = 95.1>
<EMI ID = 96.1>
<EMI ID = 97.1>
<EMI ID = 98.1>
<EMI ID = 99.1>
<EMI ID = 100.1>
<EMI ID = 101.1>
<EMI ID = 102.1> <EMI ID = 103.1>
<EMI ID = 104.1>
<EMI ID = 105.1> <EMI ID = 106.1>
E � KFf � 1 �
<EMI ID = 107.1>
follows)
<EMI ID = 108.1>
<EMI ID = 109.1>
<EMI ID = 110.1>
<EMI ID = 111.1>
<EMI ID = 112.1>
<EMI ID = 113.1>
VB �te;
<EMI ID = 114.1>
<EMI ID = 115.1>
<EMI ID = 116.1>
<EMI ID = 117.1> <EMI ID = 118.1>
<EMI ID = 119.1>
<EMI ID = 120.1>
<EMI ID = 121.1>
<EMI ID = 122.1>
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4695/75A GB1496011A (en) | 1974-11-22 | 1975-02-04 | Defoaming composition |
Publications (1)
Publication Number | Publication Date |
---|---|
BE838273A true BE838273A (en) | 1976-08-04 |
Family
ID=9782062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE164096A BE838273A (en) | 1975-02-04 | 1976-02-04 | IMMUNOLOGICAL CYTOTOXIC AGENTS |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS51126281A (en) |
BE (1) | BE838273A (en) |
DK (1) | DK43676A (en) |
NL (1) | NL7601132A (en) |
SE (1) | SE7601125L (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2586564A1 (en) * | 1985-09-04 | 1987-03-06 | Pierre Tran Ba Loc | Immunosuppressant compounds and process for preparing them |
EP0279862A4 (en) * | 1986-08-28 | 1990-01-08 | Teijin Ltd | Cytocidal antibody complex and process for its preparation. |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57143326A (en) * | 1981-03-03 | 1982-09-04 | Teijin Ltd | Polymer linked to cellular toxic substance and its preparation |
DE3205847A1 (en) * | 1981-05-08 | 1982-12-16 | Farmitalia Carlo Erba S.p.A., 20159 Milano | Daunorubicin-protein conjugates |
JPS60172935A (en) * | 1984-02-16 | 1985-09-06 | Green Cross Corp:The | Preparation of composite material of substance having carcinostatic action |
JPS611622A (en) * | 1984-06-14 | 1986-01-07 | Teijin Ltd | Cytotoxic complex and preparation thereof |
JPS62228025A (en) * | 1985-12-27 | 1987-10-06 | Teijin Ltd | Production of antibody complex |
JPH0662438B1 (en) * | 1986-08-28 | 1994-08-17 | Teijin Ltd | |
US5149782A (en) * | 1988-08-19 | 1992-09-22 | Tanox Biosystems, Inc. | Molecular conjugates containing cell membrane-blending agents |
JP2626654B2 (en) * | 1990-03-31 | 1997-07-02 | 科学技術振興事業団 | Targeting high molecular weight pharmaceutical compounds and intermediates thereof |
-
1976
- 1976-02-03 SE SE7601125A patent/SE7601125L/en not_active Application Discontinuation
- 1976-02-03 DK DK43676*#A patent/DK43676A/en not_active Application Discontinuation
- 1976-02-03 JP JP51010786A patent/JPS51126281A/en active Pending
- 1976-02-04 NL NL7601132A patent/NL7601132A/en not_active Application Discontinuation
- 1976-02-04 BE BE164096A patent/BE838273A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2586564A1 (en) * | 1985-09-04 | 1987-03-06 | Pierre Tran Ba Loc | Immunosuppressant compounds and process for preparing them |
EP0279862A4 (en) * | 1986-08-28 | 1990-01-08 | Teijin Ltd | Cytocidal antibody complex and process for its preparation. |
Also Published As
Publication number | Publication date |
---|---|
DK43676A (en) | 1976-08-05 |
NL7601132A (en) | 1976-08-06 |
JPS51126281A (en) | 1976-11-04 |
SE7601125L (en) | 1976-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT7927250A0 (en) | MAGNESIUM-BASED COMPOSITION FOR THE STORAGE OF HYDROGEN AND PROCEDURE FOR THE PREPARATION OF THIS COMPOSITION. | |
BE838273A (en) | IMMUNOLOGICAL CYTOTOXIC AGENTS | |
IT8721140V0 (en) | STRUCTURE OF CLOTHES HANGERS WITH VARIABLE CONFIGURATION WITH ACCESSORY HOLDERS, PARTICULARLY FOR THE EXPOSURE OF CLOTHING IN GENERAL. | |
DE3883132D1 (en) | SYNCHRONOUS SEMICONDUCTOR STORAGE DEVICE. | |
FR2585736B3 (en) | MOLLETON KNITTED ARTICLE AND LAMINATED COMPLEX MADE FROM SUCH AN ARTICLE. | |
BE884749A (en) | CATALYTIC AMENDMENT | |
BE837986A (en) | MORE HOOK | |
GB2020285B (en) | Pharmacologically active 1,3-benzodioxine dervatives | |
BE877078A (en) | STIRRIER. | |
BE840688A (en) | VETON STEEL COMPOSITE BRIDGE | |
BE879341A (en) | HENGELHAAK | |
BE840009Q (en) | PROTECTIVE COLLAR | |
BE835850A (en) | DENTAL PROSTHESIS | |
BE872701A (en) | TRANSPORT DEVICE | |
BE840716A (en) | IRRADIATION INSTALLATION | |
BE840497A (en) | PERFECTED TENT | |
BE840633A (en) | SWIVEL SEAT FOR DISABLED PERSONS | |
BE840127A (en) | GYMNASTIK ELEMENTE | |
BE840979A (en) | GOODS CARRIER | |
BE840249A (en) | FONDERINGSPAAL | |
BE841028A (en) | DISHWASHER DEVICE | |
BE840956A (en) | PHOTO ELECTRICAL DETECTOR | |
BE838280A (en) | MONOAZOIC AND DIAZOIC COLORANTS | |
BE840706A (en) | PERFECTED BRUSH | |
FR2616661B1 (en) | ORAL-BASED MUCOPOLYSACCHARIDE-BASED COMPOSITION |